SANTORINI-MXNCT07930975
Lipid Management Gaps in Mexican Patients at High and Very High Cardiovascular Risk
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Secondary (15)
Show 10 moreShow less
Arms and interventions
Adults aged 18 years or older classified as having high or very high cardiovascular risk according to the 2019 ESC/EAS guidelines, who are receiving or have a clinical indication for lipid-lowering therapy. Participants will be consecutively enrolled at participating healthcare centers in Mexico and assessed at baseline and after 12 ± 2 months. Lipid levels, cardiovascular risk factors, lipid-lowering treatments, treatment intensification, medication adherence, and barriers to optimal lipid management will be recorded. All treatments will be prescribed according to routine clinical practice, without protocol-assigned interventions.
Drugs: Lipid-Lowering Therapy in Routine Clinical Practice
Sites
1 site in 1 country
- Instituto Nacional de Ciencias Médicas y Nutrición Salvador ZubiránMexico City, Mexico City, Mexico